Loading...
Growth hormone secretagogues and peptides affecting the endocrine system. Research includes compounds that stimulate natural hormone production and support hormonal balance.
A synthetic growth hormone-releasing hormone analogue designed for extended half-life and sustained growth hormone secretion.
View detailsA selective growth hormone-releasing peptide known for its favourable side effect profile, stimulating GH release without significantly affecting cortisol or prolactin.
View detailsA truncated form of natural GHRH that was the first GHRH analogue approved for clinical use, used for GH deficiency diagnosis and treatment.
View detailsA potent growth hormone-releasing peptide that stimulates GH secretion through the ghrelin receptor, with additional effects on appetite and cortisol.
View detailsThe first clinically evaluated growth hormone-releasing peptide, notable for its potent GH release and pronounced appetite-stimulating effects.
View detailsA potent growth hormone-releasing peptide with notable cardioprotective properties independent of GH release.
View detailsAn FDA-approved growth hormone releasing hormone analogue used to reduce excess abdominal fat in HIV patients with lipodystrophy.
View detailsA modified, highly potent analogue of insulin-like growth factor 1 with extended half-life and reduced binding protein affinity.
View detailsA PEGylated version of mechano growth factor with extended half-life, researched for muscle repair and hypertrophy.
View detailsA decapeptide hormone critical for initiating puberty and regulating reproductive hormone release, with emerging research applications.
View detailsA pituitary hormone that stimulates cortisol production, used diagnostically and therapeutically for various conditions including infantile spasms.
View detailsA natural glycoprotein that inhibits myostatin and activins, researched for muscle growth and metabolic effects.
View detailsA hypothalamic tripeptide that regulates thyroid function and has diverse effects on the brain and metabolism.
View detailsA myostatin/activin decoy receptor designed to promote muscle growth, researched for muscular dystrophy but development discontinued.
View detailsA thyroid hormone involved in calcium regulation, used therapeutically for osteoporosis, Paget's disease, and hypercalcemia.
View detailsThe biologically active fragment of parathyroid hormone approved for osteoporosis treatment, representing the first anabolic bone therapy.
View detailsA glycoprotein hormone that stimulates red blood cell production, used medically to treat anaemia.
View detailsThe master hypothalamic hormone controlling reproductive function, with both agonist and antagonist analogues used therapeutically.
View detailsA potent, orally active non-peptide growth hormone secretagogue that mimics ghrelin to stimulate sustained GH and IGF-1 elevation, widely researched for body composition, sleep, and bone density.
View detailsA modified growth hormone releasing hormone (GHRH) analogue featuring a Drug Affinity Complex (DAC) that extends its half-life to approximately 8 days, enabling sustained growth hormone elevation with less frequent dosing.
View detailsMonograph coming soon.
Monograph coming soon.
Monograph coming soon.
Monograph coming soon.